| Glioma targeted therapy: insight into future of molecular approaches K Yang, Z Wu, H Zhang, N Zhang, W Wu, Z Wang, Z Dai, X Zhang, ... Molecular cancer 21 (1), 39, 2022 | 509 | 2022 |
| PARP inhibitor resistance: the underlying mechanisms and clinical implications H Li, ZY Liu, N Wu, YC Chen, Q Cheng, J Wang Molecular cancer 19, 1-16, 2020 | 425 | 2020 |
| Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer H Zhang, Z Dai, W Wu, Z Wang, N Zhang, L Zhang, WJ Zeng, Z Liu, ... Journal of Experimental & Clinical Cancer Research 40 (1), 184, 2021 | 367 | 2021 |
| Immunosenescence: molecular mechanisms and diseases Z Liu, Q Liang, Y Ren, C Guo, X Ge, L Wang, Q Cheng, P Luo, Y Zhang, ... Signal transduction and targeted therapy 8 (1), 200, 2023 | 327 | 2023 |
| Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts Y Wang, H Zhang, C Liu, Z Wang, W Wu, N Zhang, L Zhang, J Hu, P Luo, ... Journal of Hematology & Oncology 15 (1), 111, 2022 | 187 | 2022 |
| Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials H Zhang, X Yue, Z Chen, C Liu, W Wu, N Zhang, Z Liu, L Yang, Q Jiang, ... Molecular Cancer 22 (1), 159, 2023 | 128 | 2023 |
| The molecular feature of macrophages in tumor immune microenvironment of glioma patients H Zhang, YB Luo, W Wu, L Zhang, Z Wang, Z Dai, S Feng, H Cao, ... Computational and structural biotechnology journal 19, 4603-4618, 2021 | 112 | 2021 |
| CTLA-4 correlates with immune and clinical characteristics of glioma F Liu, J Huang, X Liu, Q Cheng, C Luo, Z Liu Cancer cell international 20, 1-10, 2020 | 107 | 2020 |
| The adaptive transition of glioblastoma stem cells and its implications on treatments Z Wang, H Zhang, S Xu, Z Liu, Q Cheng Signal transduction and targeted therapy 6 (1), 124, 2021 | 101 | 2021 |
| CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer A Lin, C Qi, T Wei, M Li, Q Cheng, Z Liu, P Luo, J Zhang Briefings in bioinformatics 23 (3), bbac129, 2022 | 89 | 2022 |
| Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database C Zhou, S Peng, A Lin, A Jiang, Y Peng, T Gu, Z Liu, Q Cheng, J Zhang, ... EClinicalMedicine 59, 2023 | 85 | 2023 |
| Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma N Zhang, H Zhang, W Wu, R Zhou, S Li, Z Wang, Z Dai, L Zhang, F Liu, ... Theranostics 12 (13), 5931, 2022 | 83 | 2022 |
| Minimally invasive surgery is superior to conventional craniotomy in patients with spontaneous supratentorial intracerebral hemorrhage: a systematic review and meta-analysis Z Xia, X Wu, J Li, Z Liu, F Chen, L Zhang, H Zhang, X Wan, Q Cheng World neurosurgery 115, 266-273, 2018 | 78 | 2018 |
| The basic characteristics of the pentraxin family and their functions in tumor progression Z Wang, X Wang, H Zou, Z Dai, S Feng, M Zhang, G Xiao, Z Liu, Q Cheng Frontiers in Immunology 11, 1757, 2020 | 71 | 2020 |
| Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma H Zhang, N Zhang, W Wu, R Zhou, S Li, Z Wang, Z Dai, L Zhang, Z Liu, ... Briefings in bioinformatics 23 (6), bbac386, 2022 | 70 | 2022 |
| MicroRNA-203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2 Retraction in/10.3892/mmr. 2023.13154 Z Chen, D Li, Q Cheng, Z Ma, B Jiang, R Peng, R Chen, Y Cao, X Wan Molecular medicine reports 9 (2), 503-508, 2014 | 70 | 2014 |
| PDIA4: The basic characteristics, functions and its potential connection with cancer Z Wang, H Zhang, Q Cheng Biomedicine & Pharmacotherapy 122, 109688, 2020 | 69 | 2020 |
| Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation Z Wang, G Su, Z Dai, M Meng, H Zhang, F Fan, Z Liu, L Zhang, N Weygant, ... Cell proliferation 54 (3), e12988, 2021 | 68 | 2021 |
| MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1 Q Li, Q Cheng, Z Chen, R Peng, R Chen, Z Ma, X Wan, J Liu, M Meng, ... Oncology reports 35 (2), 1125-1134, 2016 | 64 | 2016 |
| ROCK1, a novel target of miR-145, promotes glioma cell invasion X Wan, Q Cheng, R Peng, Z Ma, Z Chen, Y Cao, B Jiang Molecular medicine reports 9 (5), 1877-1882, 2014 | 61 | 2014 |
